Symptoms
Tuberculosis may infect any part of the body, but most commonly occurs in the lungs (known as pulmonary tuberculosis).Extrapulmonary TB occurs when tuberculosis develops outside of the lungs.
General signs and symptoms include fever, chills, night sweats, loss of appetite, weight loss, and fatigue. Significant nail clubbing may also occur.
Pulmonary
If a tuberculosis infection does become active, it most commonly involves the lungs (in about 90% of cases). Symptoms may include chest pain and a prolonged cough producing sputum. About 25% of people may not have any symptoms (i.e. they remain "asymptomatic"). Occasionally, people may cough up blood in small amounts, and in very rare cases, the infection may erode into the pulmonary artery or a Rasmussen's aneurysm, resulting in massive bleeding. Tuberculosis may become a chronic illness and cause extensive scarring in the upper lobes of the lungs. The upper lung lobes are more frequently affected by tuberculosis than the lower ones.
Extrapulmonary
In 15–20% cases, the infection spreads outside the lungs, causing other kinds of TB. These are collectively denoted as "extrapulmonary tuberculosis". Extrapulmonary TB occurs more commonly in immunosuppressed persons and young children. In those with HIV, this occurs in more than 50% of cases. Notable extrapulmonary infection sites include the pleura (in tuberculous pleurisy), the central nervous system (in tuberculous meningitis), the lymphatic system (in scrofula of the neck), the genitourinary system (in urogenital tuberculosis), and the bones and joints (in Pott disease of the spine), among others. When it spreads to the bones, it is also known as "osseous tuberculosis", a form of osteomyelitis. Sometimes, bursting of a tubercular abscess through skin results in tuberculous ulcer. An ulcer originating from nearby infected lymph nodes is painless, slowly enlarging and has an appearance of "wash leather". A potentially more serious, widespread form of TB is called "disseminated tuberculosis", also known as miliary tuberculosis. Miliary TB makes up about 10% of extrapulmonary cases.
- Pulmonary
- Extrapulmonary
- Active phase
- latent phase
Related Conference of Symptoms
8th International Conference on Clinical Microbiology, Virology and Infectious Diseases
6th International Conference on Applied Microbiology and Infectious Diseases
11th International Congress on Trauma, Critical Care and Emergency Medicine
20th International Conference on Microbial Interactions & Microbial Ecology
20th International Conference on Virology, Emerging Diseases & vaccines
10th International Conference on Molecular Medicine and Diagnostics
9th International Conference on Microbiome, Probiotics & Gut Nutrition
8th International Conference on Antimicrobial and Antibacterial Agents
Symptoms Conference Speakers
Recommended Sessions
- : Causes of Tuberculosis
- Challenges in TB diagnostics
- Diagnosis
- Epidemiology of the disease
- Genome
- Intoduction to Tuberculosis
- Mycobacterium tuberculosis infection
- New research and development
- Pathogenesis
- Prevention
- Pulmonary disorders
- Resistance to TB drugs
- Surveillance and Tracking of Drug-Resistant TB
- Symptoms
- TB and HIV co-infection
- TB clinical trials
- Treatment (Vaccines & Immunization)
Related Journals
Are you interested in
- Environmental Biology - Applied Microbiology 2025 (Canada)
- Acute Care Surgery - TRAUMA 2025 (France)
- Advanced Research In Microbiology - Applied Microbiology 2025 (UK)
- Advances in Applied Microbiology - Applied Microbiology 2025 (UK)
- Agriculture & Forest Microbiology - Microbiology 2025 (Germany)
- Agriculture & Forest Microbiology - Microbial Interactions 2025 (UK)
- Animal Virology - Euro Virology 2025 (France)
- Anti-Retroviral Therapy - Euro Virology 2025 (France)
- Antimicrobial Agents & Resistance - Microbiology 2025 (Germany)
- Antimicrobial Agents & Resistance - Microbial Interactions 2025 (UK)
- Antiviral Drug Discovery and Development - Euro Virology 2025 (France)
- Applied and Environmental Science - Microbiology 2025 (Germany)
- Applied and Environmental Science - Microbial Interactions 2025 (UK)
- Applied Microbiology - Applied Microbiology 2025 (Canada)
- Applied Microbiology in Animals - Applied Microbiology 2025 (Canada)
- Aquatic & Marine Microbiology - Microbiology 2025 (Germany)
- Aquatic & Marine Microbiology - Microbial Interactions 2025 (UK)
- Bacterial and Fungal Virology - Euro Virology 2025 (France)
- Bacteriology - Applied Microbiology 2025 (Canada)
- Bacteriology, Bacterial Pathogens & Associated diseases - Microbiology 2025 (Germany)
- Biotechnology - Applied Microbiology 2025 (UK)
- Burns and Thermal Injuries - TRAUMA 2025 (France)
- Cardiac and Vascular Emergencies - TRAUMA 2025 (France)
- Cellular Microbiology & Systems Microbiology - Microbiology 2025 (Germany)
- Cellular Microbiology & Systems Microbiology - Microbial Interactions 2025 (UK)
- Clinical and Diagnostic Virology - Euro Virology 2025 (France)
- Clinical and Neuro Virology - Virology-2025 (Canada)
- Clinical and Public Health Microbiology - Microbiology 2025 (Germany)
- Clinical and Public Health Microbiology - Microbial Interactions 2025 (UK)
- Clinical Infections and Vaccines - Microbiology 2025 (Germany)
- Clinical microbiology - Applied Microbiology 2025 (UK)
- Coronavirus (COVID-19) - Euro Virology 2025 (France)
- Critical Care Medicine - TRAUMA 2025 (France)
- Current Focus in Virology Research - Euro Virology 2025 (France)
- Emergency Nursing and Trauma Care - TRAUMA 2025 (France)
- Emerging infectious diseases and the - Virology-2025 (Canada)
- Emerging Infectious Diseases in Critical Care - TRAUMA 2025 (France)
- Environmental Microbiology - Applied Microbiology 2025 (UK)
- Environmental Microbiology (Soil Microbiology & Water Microbiology) - Microbiology 2025 (Germany)
- Epidemiology of Re-Emerging Infectious Diseases - Virology-2025 (Canada)
- Ethics, Legal, and Policy Issues in Critical Care - TRAUMA 2025 (France)
- Food & Marine Microbiology - Microbial Interactions 2025 (UK)
- Food Borne Diseases and Prevention - Food Microbiology-2025 (UK)
- Food Microbiology - Microbiology 2025 (Germany)
- Food Microbiology - Applied Microbiology 2025 (UK)
- Food Microbiology - Food Microbiology-2025 (UK)
- Food Microbiology and Food Market - Microbiology 2025 (Germany)
- Food Mycology - Food Microbiology-2025 (UK)
- Food Safety and Quality - Food Microbiology-2025 (UK)
- Gastrointestinal viral diseases - Euro Virology 2025 (France)
- General Virology - Virology-2025 (Canada)
- General Virology - Euro Virology 2025 (France)
- Geomicrobiology - Applied Microbiology 2025 (Canada)
- Geriatric Trauma and Emergency Care - TRAUMA 2025 (France)
- Global Health and Trauma Care - TRAUMA 2025 (France)
- Hepatic viral diseases - Euro Virology 2025 (France)
- Host-Pathogen Interaction - Microbial Interactions 2025 (UK)
- Host-Pathogen Interactions - Applied Microbiology 2025 (Canada)
- Human Micro Biota - Applied Microbiology 2025 (Canada)
- Immunization and Immunotherapeutics - Virology-2025 (Canada)
- Industrial Microbiology - Applied Microbiology 2025 (UK)
- Industrial Microbiology, Microbial Biotechnology and Future Bioindustries - Microbiology 2025 (Germany)
- Industrial Microbiology, Microbial Biotechnology and Future Bioindustries - Microbial Interactions 2025 (UK)
- Influenza and other Respiratory Diseases - Virology-2025 (Canada)
- Innovations and Technology in Trauma and Critical Care - TRAUMA 2025 (France)
- Insect vector and virus epidemiology - Euro Virology 2025 (France)
- Measles as re-emerging infectious disease - Virology-2025 (Canada)
- Medical Microbiology - Applied Microbiology 2025 (UK)
- Medical Parasitology - Microbiology 2025 (Germany)
- Microbial Biodegradation - Microbial Interactions 2025 (UK)
- Microbial Biotechnology - Applied Microbiology 2025 (UK)
- Microbial Community - Microbial Interactions 2025 (UK)
- Microbial Cytology, Microbial Physiology & Recombination DNA - Microbiology 2025 (Germany)
- Microbial Diseases - Microbial Interactions 2025 (UK)
- Microbial Ecology and Evolution - Microbiology 2025 (Germany)
- Microbial Ecology and Evolution - Microbial Interactions 2025 (UK)
- Microbial Ecology of Food - Food Microbiology-2025 (UK)
- Microbial Interactions - Microbial Interactions 2025 (UK)
- Microbial Pathogenesis - Microbial Interactions 2025 (UK)
- Microbiology - Euro Virology 2025 (France)
- Microbiology & Infectious Diseases - Microbial Interactions 2025 (UK)
- Microbiology & Microbes World - Applied Microbiology 2025 (Canada)
- Microbiology & Molecular Biology: - Applied Microbiology 2025 (UK)
- Microbiology of Fermented Foods and Beverages - Food Microbiology-2025 (UK)
- Microorganisms in Pharmaceutical Industry - Applied Microbiology 2025 (Canada)
- Military and Combat Trauma - TRAUMA 2025 (France)
- Molecular and Cellular Virology - Euro Virology 2025 (France)
- Molecular Microbiology - Microbiology 2025 (Germany)
- Molecular Microbiology - Microbial Interactions 2025 (UK)
- Mycology, Fungal Pathogens and Associated Diseases - Microbiology 2025 (Germany)
- Mycology, Fungal Pathogens and Associated Diseases - Microbial Interactions 2025 (UK)
- Neurologic viral diseases - Euro Virology 2025 (France)
- Neurological Emergencies and Trauma - TRAUMA 2025 (France)
- New and Endogenous Retroviruses - Virology-2025 (Canada)
- Novel Antiviral Therapies - Virology-2025 (Canada)
- Novel Vaccine Delivery Methods - Virology-2025 (Canada)
- Oral Microbiology - Applied Microbiology 2025 (Canada)
- Pediatric and Neonatal Emergency Care - TRAUMA 2025 (France)
- Pediatric Viral Infectious Diseases - Euro Virology 2025 (France)
- Pharmaceutical microbiology - Applied Microbiology 2025 (UK)
- Phycology, Nematology & Protozoology - Microbiology 2025 (Germany)
- Plant and Agricultural Virology - Euro Virology 2025 (France)
- Plant Pathology & Microbiology - Microbiology 2025 (Germany)
- Plant Pathology & Microbiology - Microbial Interactions 2025 (UK)
- Plant-Soil Microbe Interactions - Microbial Interactions 2025 (UK)
- Probiotics & Prebiotics - Applied Microbiology 2025 (Canada)
- Profession of Microbiology - Microbiology 2025 (Germany)
- Psychosocial Aspects of Trauma and Critical Care - TRAUMA 2025 (France)
- Public health & Epidemiology - Applied Microbiology 2025 (Canada)
- Respiratory viral diseases - Euro Virology 2025 (France)
- Resuscitation and Emergency Response - TRAUMA 2025 (France)
- Risk Assessment and Risk Management - Food Microbiology-2025 (UK)
- Soil microbiology & Water Microbiology - Microbial Interactions 2025 (UK)
- STD & HIV/ AIDS and Emerging Viral Diseases - Euro Virology 2025 (France)
- STD's and Non-Viral STIs - Virology-2025 (Canada)
- Structural and Molecular virology - Virology-2025 (Canada)
- Transmission of Viruses - Virology-2025 (Canada)
- Transplant-Associated Viral Infections - Virology-2025 (Canada)
- Trauma and Emergency Care Research - TRAUMA 2025 (France)
- Trauma and Emergency Medicine - TRAUMA 2025 (France)
- Trauma and Emergency Medicine Education - TRAUMA 2025 (France)
- Trauma Imaging and Diagnostics - TRAUMA 2025 (France)
- Trauma Rehabilitation and Recovery - TRAUMA 2025 (France)
- Uses of Microorganisms in Food - Food Microbiology-2025 (UK)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2025 (Canada)
- Vaccines against tropical and neglected diseases - Virology-2025 (Canada)
- Vaccines and the Microbiome - Virology-2025 (Canada)
- Veterinary Microbiology - Microbiology 2025 (Germany)
- Veterinary virology - Virology-2025 (Canada)
- Viral Genetics, Evolution and Dynamics - Virology-2025 (Canada)
- Viral Immunology - Euro Virology 2025 (France)
- Viral Immunology and Immunopathology - Virology-2025 (Canada)
- Viral Oncology - Virology-2025 (Canada)
- Viral Oncology - Euro Virology 2025 (France)
- Viral Pathogenesis - Virology-2025 (Canada)
- Viral Vaccines - Euro Virology 2025 (France)
- Virology, Viral Pathogens and Associated Diseases - Microbiology 2025 (Germany)